Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: dancin fox who wrote (879)	2/6/1999 10:55:00 AM
From: vestor	Respond to of 1837

If the reps at AHP are being briefed on how to handle the introduction of Cenestin then it is possible that they believe that they will not be able to stop Duramed this go around.... Thus if I were a rep I just might find it a good reason to buy some DRMD and tell my friends....

To: dancin fox who wrote (879)	2/6/1999 11:05:00 AM
From: Doug Bean	Read Replies (1) \| Respond to of 1837

Fox: I think you may be right on both counts,, that is , a blend of the two. A drug approval and the resulting volume alerting shorts and other who watch DRMD for these run ups. yes they have done it before. However within that run up run down theory one has to be careful that they don't get aced out when the big one is approved. If I was inclined to play it that way i'd hold until i knew for sure it was not Cenestin and then sell and wait til it drops back a bit. That said i have to also say that i am simply going to hold until Cenestin is approved or rejected. I do not want to take any chance of being out of DRMD when the approval comes :-) CRDoug